The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 175.80
Bid: 174.80
Ask: 175.40
Change: 3.60 (2.09%)
Spread: 0.60 (0.343%)
Open: 170.00
High: 178.20
Low: 170.00
Prev. Close: 172.20
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 May 2019 15:08

RNS Number : 7179Y
Forterra plc
10 May 2019
 

10 May 2019

Forterra plc

Forterra plc (the "Company")

Director / PDMR Shareholdings

Following the vesting on 26 April 2019 of share options granted to management under the 2016 Performance Share Plan (PSP), the Company was notified on the 9 and 10 May 2019 that on the 8 and 9 May the following exercise and sale transactions took place:

Stephen Harrison, Shatish Dasani, Ben Guyatt and George Stewart exercised options granted under the PSP as laid out below selling sufficient shares to cover the appropriate tax and national insurance liabilities. In addition, George Stewart also exercised options granted under the Deferred Annual Bonus Plan (DABP) which had vested in 2018. Again, sufficient shares were sold to meet the appropriate tax and national insurance liabilities with the balance being retained.

Name

Status

No. of shares exercised

Sale Date

Number of shares sold

Price

Number of shares retained

Beneficial interest

% of ISC

PSP

DABP

Stephen Harrison

PDMR

204,073

8/5/19

96,252

£2.883

107,821

134,532

< 1%

Ben Guyatt

PDMR

35,712

8/5/19

16,844

£2.883

18,868

24,424

< 1%

George Stewart

PDMR

24,488

17,306

8/5/19

19,713

£2.883

22,081

31,183

< 1%

Shatish Dasani

PDMR

122,443

9/5/19

57,751

£2.825

64,692

177,475

< 1%

The 2016 PSP awards were granted with half of the awards subject to an EPS performance condition and the other half of the awards subject to a TSR performance condition. The EPS performance condition vested at 36.9% of the maximum and the TSR performance condition vested at 100% of the maximum. The Remuneration Committee determined that, in accordance with the rules of the scheme, participants would receive dividend equivalent shares at the rate of 0.073294 additional share for every vesting share. The Remuneration Committee also agreed to waive the 1p per option cost upon exercise.

The shares to be retained by management are to be transferred to management by the Employee Benefit Trust.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Ben Guyatt (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Stephen Harrison

2.

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP scheme on 31 May 2016 and vesting on 26 April 2019

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.883

 

 

£Nil

204,073 options vesting

 

96,252 shares sold to settle tax and NI

 

107,821 shares acquired

 

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.883

96,252

£277,795

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ben Guyatt

2.

Reason for the notification

a)

Position/status

PDMR (Director of Finance and Company Secretary)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP scheme on 31 May 2016 and vesting on 26 April 2019

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.883

 

 

£Nil

 

 

35,712 options vesting

 

16,844 shares sold to settle tax and NI

 

18,868 shares acquired

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.883

16,844

£48,561

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

George Stewart

2.

Reason for the notification

a)

Position/status

PDMR (Operations Director)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP on 31 May 2016 and vesting on 26 April 2019 along with options granted under the DABP granted on 1 June 2016 and vesting on 26 April 2018

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.883

 

 

£Nil

 

41,794 options vesting

 

19,713 shares sold to settle tax and NI

 

22,081 shares acquired

 

 

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.883

19,713

£56,833

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Shatish Dasani

2.

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP on 31 May 2016 and vesting on 26 April 2019

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

 

£Nil

 

 

£2.825

 

 

£Nil

 

122,443 options vesting

 

57,751 shares sold to settle tax and NI

 

64,692 shares acquired

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 Sale

£2.825

57,751

£163,147

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGGUAUAUPBGCU
Date   Source Headline
2nd May 202410:46 amRNSGrant under Performance Share Plan
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase
25th Apr 20237:00 amRNSNotification of Board Changes
11th Apr 20234:15 pmRNSPCA Shareholdings
4th Apr 20231:12 pmRNSEmployee Benefit Trust Share Purchase
3rd Apr 20232:03 pmRNSGrant under Performance Share Plan
29th Mar 202310:21 amRNSAnnual Report & Accounts 2022 & Notice of AGM 2023
16th Mar 20235:28 pmRNSGrant under Deferred Annual Bonus Plan
10th Mar 20239:18 amRNSProgressive publishes new research
9th Mar 20237:02 amRNSAppointment of Independent Non-Executive Director
9th Mar 20237:00 amRNSFull Year Results
3rd Mar 20232:18 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 202310:13 amRNSEmployee Benefit Trust Share Purchase
1st Feb 20238:18 amRNSDirector Declaration
25th Jan 20237:00 amRNSTrading Update
5th Jan 20233:12 pmRNSEmployee Benefit Trust Share Purchase
14th Dec 20225:10 pmRNSEmployee Benefit Trust Share Purchase
8th Dec 20227:00 amRNSHolding(s) in Company
2nd Dec 20224:10 pmRNSEmployee Benefit Trust Share Purchase
22nd Nov 20227:54 amRNSProgressive publishes new research
22nd Nov 20227:01 amRNSAppointment of Chief Executive Officer
22nd Nov 20227:00 amRNSTrading Update
4th Nov 20222:50 pmRNSEmployee Benefit Trust Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.